OKYO Pharma Management
Management criteria checks 3/4
OKYO Pharma's CEO is Gary Jacob, appointed in Jan 2021, has a tenure of 3.83 years. total yearly compensation is $1.11M, comprised of 35.2% salary and 64.8% bonuses, including company stock and options. directly owns 0.14% of the company’s shares, worth €45.60K. The average tenure of the management team and the board of directors is 3.8 years and 3.4 years respectively.
Key information
Gary Jacob
Chief executive officer
US$1.1m
Total compensation
| CEO salary percentage | 35.2% |
| CEO tenure | 3.8yrs |
| CEO ownership | 0.1% |
| Management average tenure | 3.8yrs |
| Board average tenure | 3.4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | US$1m | US$392k | -US$17m |
| Mar 31 2023 | US$1m | US$433k | -US$13m |
| Dec 31 2022 | n/a | n/a | -US$11m |
| Sep 30 2022 | n/a | n/a | -US$7m |
| Jun 30 2022 | n/a | n/a | -US$6m |
| Mar 31 2022 | US$2m | US$350k | -US$5m |
| Dec 31 2021 | n/a | n/a | -US$5m |
| Sep 30 2021 | n/a | n/a | -US$5m |
| Jun 30 2021 | n/a | n/a | -US$4m |
| Mar 31 2021 | US$872k | US$85k | -US$3m |
Compensation vs Market: Gary's total compensation ($USD1.11M) is above average for companies of similar size in the German market ($USD474.54K).
Compensation vs Earnings: Gary's compensation has been consistent with company performance over the past year.
CEO
Gary Jacob (77 yo)
3.8yrs
Tenure
US$1,114,000
Compensation
Dr. Gary S. Jacob, PhD, served as an Independent Director at Virpax Pharmaceuticals, Inc. since April 2020 until July 25, 2022. He had been an Independent Director of Cardiff Oncology, Inc. since February...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 3.8yrs | US$1.11m | 0.14% € 45.6k | |
| Founder | no data | no data | no data | |
| Chief Financial Officer | 4.3yrs | no data | no data | |
| Chief Scientific Officer | 3.7yrs | no data | no data |
3.8yrs
Average Tenure
66yo
Average Age
Experienced Management: OK11's management team is considered experienced (3.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 3.8yrs | US$1.11m | 0.14% € 45.6k | |
| Independent Non-Executive Director | 2.9yrs | US$51.00k | 0% € 0 | |
| Non-Executive Chairman | 3.8yrs | US$1.31m | 29.12% € 9.8m | |
| Independent Non-Executive Director | 4.4yrs | US$86.00k | 0.025% € 8.5k | |
| Member of Scientific Advisory Board | 1.8yrs | no data | no data | |
| Senior Independent Non-Executive Director | 9yrs | US$50.00k | 0.026% € 8.9k | |
| Member of Scientific Advisory Board | 4.3yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data |
3.4yrs
Average Tenure
73yo
Average Age
Experienced Board: OK11's board of directors are considered experienced (3.4 years average tenure).